Cargando…
Type IIb Heat Labile Enterotoxin B Subunit as a Mucosal Adjuvant to Enhance Protective Immunity against H5N1 Avian Influenza Viruses
Human infections with highly pathogenic avian influenza H5N1 viruses persist as a major global health concern. Vaccination remains the primary protective strategy against H5N1 and other novel avian influenza virus infections. We investigated the use of E. coli type IIb heat labile enterotoxin B subu...
Autores principales: | Tang, Neos, Lu, Chun-Yi, Sue, Shih-Che, Chen, Ting-Hsuan, Jan, Jia-Tsrong, Huang, Ming-Hsi, Huang, Chung-Hsiung, Chen, Chung-Chu, Chiang, Bor-Luen, Huang, Li-Min, Wu, Suh-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768441/ https://www.ncbi.nlm.nih.gov/pubmed/33266210 http://dx.doi.org/10.3390/vaccines8040710 |
Ejemplares similares
-
Highly Pathogenic Avian Influenza H5 Hemagglutinin Fused with the A Subunit of Type IIb Escherichia coli Heat Labile Enterotoxin Elicited Protective Immunity and Neutralization by Intranasal Immunization in Mouse and Chicken Models
por: Tang, Neos, et al.
Publicado: (2019) -
Use of PELC/CpG Adjuvant for Intranasal Immunization with Recombinant Hemagglutinin to Develop H7N9 Mucosal Vaccine
por: Chen, Ting-Hsuan, et al.
Publicado: (2020) -
An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites
por: Sun, Nan, et al.
Publicado: (2017) -
Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation
por: Zhao, Liang, et al.
Publicado: (2014) -
Parenteral adjuvant potential of recombinant B subunit of
Escherichia coli heat-labile enterotoxin
por: da Cunha, Carlos Eduardo Pouey, et al.
Publicado: (2017)